BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28000843)

  • 21. Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice.
    Honda T; Ishigami M; Luo F; Lingyun M; Ishizu Y; Kuzuya T; Hayashi K; Nakano I; Ishikawa T; Feng GG; Katano Y; Kohama T; Kitaura Y; Shimomura Y; Goto H; Hirooka Y
    Metabolism; 2017 Apr; 69():177-187. PubMed ID: 28285648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3/AMPK/ACC Pathway.
    Zhang YP; Deng YJ; Tang KR; Chen RS; Liang S; Liang YJ; Han L; Jin L; Liang ZE; Chen YN; Yang QH
    Curr Med Sci; 2019 Feb; 39(1):37-43. PubMed ID: 30868489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.
    Boland ML; Oldham S; Boland BB; Will S; Lapointe JM; Guionaud S; Rhodes CJ; Trevaskis JL
    World J Gastroenterol; 2018 Apr; 24(16):1748-1765. PubMed ID: 29713129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Terf2ip deficiency accelerates non-alcoholic steatohepatitis through regulating lipophagy and fatty acid oxidation via Sirt1/AMPK pathway.
    Wang Y; Liu S; Ni M; Chen Y; Chen R; Wang J; Jiang W; Zhou T; Fan S; Chang J; Xu X; Zhang Y; Yu Y; Li X; Li C
    Free Radic Biol Med; 2024 Aug; 220():78-91. PubMed ID: 38697492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caffeine ameliorates high energy diet-induced hepatic steatosis: sirtuin 3 acts as a bridge in the lipid metabolism pathway.
    Zhang SJ; Li YF; Wang GE; Tan RR; Tsoi B; Mao GW; Zhai YJ; Cao LF; Chen M; Kurihara H; Wang Q; He RR
    Food Funct; 2015 Aug; 6(8):2578-87. PubMed ID: 26114447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Branched-Chain Amino Acid-Rich Supplements Containing Microelements Have Antioxidant Effects on Nonalcoholic Steatohepatitis in Mice.
    Tanaka H; Fukahori S; Baba S; Ueno T; Sivakumar R; Yagi M; Asagiri K; Ishii S; Tanaka Y
    JPEN J Parenter Enteral Nutr; 2016 May; 40(4):519-28. PubMed ID: 25316683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic metabolic adaptation and adipose tissue expansion are altered in mice with steatohepatitis induced by high-fat high sucrose diet.
    Baiges-Gaya G; Fernández-Arroyo S; Luciano-Mateo F; Cabré N; Rodríguez-Tomàs E; Hernández-Aguilera A; Castañé H; Romeu M; Nogués MR; Camps J; Joven J
    J Nutr Biochem; 2021 Mar; 89():108559. PubMed ID: 33264665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bouchardatine analogue alleviates non-alcoholic hepatic fatty liver disease/non-alcoholic steatohepatitis in high-fat fed mice by inhibiting ATP synthase activity.
    Rao Y; Lu YT; Li C; Song QQ; Xu YH; Xu Z; Hu YT; Yu H; Gao L; Gu LQ; Ye JM; Huang ZS
    Br J Pharmacol; 2019 Aug; 176(16):2877-2893. PubMed ID: 31113010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strain- and time-dependent alterations in hepatic iron metabolism in a murine model of nonalcoholic steatohepatitis.
    Bloomer SA; Olivier AK; Bergmann OM; Mathahs MM; Broadhurst KA; Hicsasmaz H; Brown KE
    Cell Biochem Funct; 2016 Dec; 34(8):628-639. PubMed ID: 27935134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloid AMPK signaling restricts fibrosis but is not required for metformin improvements during CDAHFD-induced NASH in mice.
    Nunes JRC; O'Dwyer C; Ghorbani P; Smith TKT; Chauhan S; Robert-Gostlin V; Girouard MD; Viollet B; Foretz M; Fullerton MD
    J Lipid Res; 2024 Jun; 65(6):100564. PubMed ID: 38762124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monkfish Peptides Mitigate High Fat Diet-Induced Hepatic Steatosis in Mice.
    Ye J; Tian X; Wang Q; Zheng J; Yang Y; Xu B; Zhang S; Yuan F; Yang Z
    Mar Drugs; 2022 May; 20(5):. PubMed ID: 35621963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of
    Park M; Kang C; Lee HJ
    Curr Issues Mol Biol; 2021 Apr; 43(1):21-35. PubMed ID: 33925122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
    Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation.
    Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M
    Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SLC7A11-ROS/αKG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression.
    Lv T; Fan X; He C; Zhu S; Xiong X; Yan W; Liu M; Xu H; Shi R; He Q
    Redox Biol; 2024 Jun; 72():103159. PubMed ID: 38642501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Mogrosides on High-Fat-Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice.
    Zhang X; Song Y; Ding Y; Wang W; Liao L; Zhong J; Sun P; Lei F; Zhang Y; Xie W
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30060618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Combination of Mitochondrial Oxidative Stress and Excess Fat/Calorie Intake Accelerates Steatohepatitis by Enhancing Hepatic CC Chemokine Production in Mice.
    Moro T; Nakao S; Sumiyoshi H; Ishii T; Miyazawa M; Ishii N; Sato T; Iida Y; Okada Y; Tanaka M; Hayashi H; Ueha S; Matsushima K; Inagaki Y
    PLoS One; 2016; 11(1):e0146592. PubMed ID: 26745268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats.
    Zhou X; Han D; Xu R; Wu H; Qu C; Wang F; Wang X; Zhao Y
    Oncotarget; 2016 Dec; 7(49):80223-80237. PubMed ID: 27784003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.